Merck
  • Home
  • Search Results
  • Histone deacetylase 3 (HDAC3) plays an important role in retinal ganglion cell death after acute optic nerve injury.

Histone deacetylase 3 (HDAC3) plays an important role in retinal ganglion cell death after acute optic nerve injury.

Molecular neurodegeneration (2014-09-30)
Heather M Schmitt, Heather R Pelzel, Cassandra L Schlamp, Robert W Nickells
ABSTRACT

Optic nerve damage initiates a series of early atrophic events in retinal ganglion cells (RGCs) that precede the BAX-dependent committed step of the intrinsic apoptotic program. Nuclear atrophy, including global histone deacetylation, heterochromatin formation, shrinkage and collapse of nuclear structure, and the silencing of normal gene expression, comprise an important obstacle to overcome in therapeutic approaches to preserve neuronal function. Several studies have implicated histone deacetylases (HDACs) in the early stages of neuronal cell death, including RGCs. Importantly, these neurons exhibit nuclear translocation of HDAC3 shortly after optic nerve damage. Additionally, HDAC3 activity has been reported to be selectively toxic to neurons. RGC-specific conditional knockout of Hdac3 was achieved by transducing the RGCs of Hdac3fl/fl mice with an adeno-associated virus serotype 2 carrying CRE recombinase and GFP (AAV2-Cre/GFP). Controls included similar viral transduction of Rosa26fl/fl reporter mice. Optic nerve crush (ONC) was then performed on eyes. The ablation of Hdac3 in RGCs resulted in significant amelioration of characteristics of ONC-induced nuclear atrophy such as H4 deacetylation, heterochromatin formation, and the loss of nuclear structure. RGC death was also significantly reduced. Interestingly, loss of Hdac3 expression did not lead to protection against RGC-specific gene silencing after ONC, although this effect was achieved using the broad spectrum inhibitor, Trichostatin A. Although other HDACs may be responsible for gene expression changes in RGCs, our results indicate a critical role for HDAC3 in nuclear atrophy in RGC apoptosis following axonal injury. This study provides a framework for studying the roles of other prevalent retinal HDACs in neuronal death as a result of axonal injury.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
苯酚 溶液, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, BioReagent, for molecular biology
Sigma-Aldrich
苯酚, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Sigma-Aldrich
苯酚, for molecular biology
Sigma-Aldrich
液状苯酚, ≥89.0%
Sigma-Aldrich
苯酚, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
苯酚 溶液, Saturated with 0.1 M citrate buffer, pH 4.3 ± 0.2, BioReagent, for molecular biology
Sigma-Aldrich
苯酚, ≥99%
Supelco
苯酚, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
苯酚, contains hypophosphorous as stabilizer, loose crystals, ACS reagent, ≥99.0%
Sigma-Aldrich
苯酚, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)
Sigma-Aldrich
苯酚, BioUltra, for molecular biology, TE-saturated, ~73% (T)
Sigma-Aldrich
苯酚, unstabilized, ReagentPlus®, ≥99%
Supelco
苯酚, PESTANAL®, analytical standard
Sigma-Aldrich
苯酚, puriss., meets analytical specification of Ph. Eur., BP, USP, ≥99.5% (GC), crystalline (detached)
Sigma-Aldrich
苯酚, ≥96.0% (calc. on dry substance, T)
Supelco
苯酚 溶液, 5000 μg/mL in methanol, certified reference material
Sigma-Aldrich
抗Brn-3a抗体,POU域蛋白,克隆5A3.2, culture supernatant, clone 5A3.2, Chemicon®
Supelco
苯酚 溶液, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
苯酚, unstabilized, purified by redistillation, ≥99%
Sigma-Aldrich
苯酚, natural, 97%, FG
USP
苯酚, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
抗乙酰组蛋白H4抗体, serum, Upstate®
Sigma-Aldrich
苯酚, BioUltra, for molecular biology, ≥99.5% (GC)
Supelco
苯酚 溶液, 100 μg/mL in acetonitrile, PESTANAL®, analytical standard